Engineering of extracellular vesicles for efficient intracellular delivery of multimodal therapeutics including genome editors.
Liang X. et al, (2025), Nat Commun, 16
Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in BTK/Tec double deficient X-linked agammaglobulinemia model.
Bestas B. et al, (2025), RSC Chem Biol
uORF-targeting steric block antisense oligonucleotides do not reproducibly increase RNASEH1 expression
Ahlskog N. et al, (2025), Molecular Therapy - Nucleic Acids, 36, 102406 - 102406
Activation-induced thrombospondin-4 works with thrombospondin-1 to build cytotoxic supramolecular attack particles.
Cassioli C. et al, (2025), Proc Natl Acad Sci U S A, 122
Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy.
Chwalenia K. et al, (2025), J Muscle Res Cell Motil
Tissue-specific modulation of CRISPR activity by miRNA-sensing guide RNAs.
Garcia-Guerra A. et al, (2025), Nucleic Acids Res, 53
An extracellular vesicle delivery platform based on the PTTG1IP protein.
Martin Perez C. et al, (2024), Extracell Vesicle, 4
TDP-43 regulates LC3ylation in neural tissue through ATG4B cryptic splicing inhibition.
Torres P. et al, (2024), Acta Neuropathol, 148
Multiple surgical resections for progressive IDH wildtype glioblastoma-is it beneficial?
Honeyman SI. et al, (2024), Acta Neurochir (Wien), 166
A transcriptomics-based drug repositioning approach to identify drugs with similar activities for the treatment of muscle pathologies in spinal muscular atrophy (SMA) models.
Hoolachan JM. et al, (2024), Hum Mol Genet, 33, 400 - 425
Scalable purification of extracellular vesicles with high yield and purity using multimodal flowthrough chromatography.
Bonner SE. et al, (2024), J Extracell Biol, 3
Why is early-onset atrial fibrillation uncommon in patients with Duchenne Muscular Dystrophy? Insights from the mdx mouse.
Nguyen M-N. et al, (2024), Cardiovasc Res
Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression.
González-Martínez I. et al, (2023), Mol Ther Nucleic Acids, 34
PRMT inhibitor promotes SMN2 exon 7 inclusion and synergizes with nusinersen to rescue SMA mice.
Kordala AJ. et al, (2023), EMBO Mol Med, 15
An Induced Pluripotent Stem Cell-Derived Human Blood-Brain Barrier (BBB) Model to Test the Crossing by Adeno-Associated Virus (AAV) Vectors and Antisense Oligonucleotides.
Selvakumaran J. et al, (2023), Biomedicines, 11
Modulation of Pro-Inflammatory IL-6 Trans-Signaling Axis by Splice Switching Oligonucleotides as a Therapeutic Modality in Inflammation.
Gupta D. et al, (2023), Cells, 12
EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method
Hanson B. et al, (2023), Molecular Therapy - Nucleic Acids, 33, 511 - 528
Therapeutic approaches for Duchenne muscular dystrophy.
Roberts TC. et al, (2023), Nat Rev Drug Discov